Reshma Singh

Reshma Singh

Company: Takeda

Job title: Associate Director, Cell Therapies Translational Medicine


Group Panel Discussion: Side Effects – Mitigating Against Hypotension + Fever With Immune-Stimulating Agents (NK Cell Engagers, PD-1s, Cytokines, T-Cell Engagers) = Cytokine Release Syndrome (CRS)? 11:30 am

What are the differences between the symtoms and the tests Uncover the implications for patients and regulatory bodies Examine the Implications for CAR-T Could this redefine CRS?Read more

day: Day Two

Cell Therapies Impact on Cytokines in the TME 9:30 am

Understanding how cell therapies can drastically change the cytokine microenvironment in the TME or systemically. Exploring how these changes can cause further changes to the TME and downstream cytokine production. Uncovering thoughts around the production of cell therapies in different cytokine conditions.Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.